![© Getty Images](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/biopharma-reporter.com/article/2024/07/25/agilent-snaps-up-biologics-cdmo-biovectra/17612200-1-eng-GB/Agilent-snaps-up-biologics-CDMO-BIOVECTRA.jpg)
Biologics driving M&A as Agilent snaps up specialist BIOVECTRA for $925 million
As advanced therapies drive increasing market consolidation, the US giant Agilent Technologies has acquired the Canadian contract development and manufacturing organization (CDMO) BIOVECTRA for $925 million.